The Ludwig Institute for Cancer Research reports the discovery of brain cancer cells that resist therapy via decreasing the mutation in their own genes that are targeted by the administered cancer drugs. After the drug, which is seeking this gene mutation, leave the region, the cancer cells then re-amplify these hiding genes to cause the cancer to continue to grow. This is a significant breakthrough illustrating the intense necessity for developing wittier therapies for brain cancer.
|
|
RSS Feed